AROCELL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.405 SEK | +2.53% |
|
+1.25% | -7.32% |
| 03/05 | AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 18/04 | Swedish Diagnostics Company AroCell Secures US Patent | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 88.47L | - | |||||
| 5.87TCr | - | |||||
| 4.13TCr | ||||||
| 3.92TCr | ||||||
| 2.74TCr | ||||||
| 2.65TCr |
- Stock Market
- Equities
- AROC Stock
- Charts AroCell AB
- Sector Chart
